サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1739315

自動医薬品キオスクの世界市場

Automated Drug Kiosks

出版日
ページ情報
英文 164 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
自動医薬品キオスクの世界市場
出版日: 2025年06月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 164 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自動医薬品キオスクの世界市場は2030年までに273億米ドルに達する見込み

2024年に116億米ドルと推定される自動医薬品キオスクの世界市場は、2024年から2030年にかけてCAGR 15.3％で成長し、2030年には273億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである自動ドラッグキオスクシステムは、CAGR 17.1%を記録し、分析期間終了時には196億米ドルに達すると予測されます。自動ドラッグキオスクサービスセグメントの成長率は、分析期間中CAGR 11.5%と推定されます。

米国市場は31億米ドルと推定、中国はCAGR14.3%で成長予測

米国の自動医薬品キオスク市場は、2024年に31億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに42億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは14.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ14.4％と13.0％と予測されています。欧州では、ドイツがCAGR 11.0%で成長すると予測されています。

世界の自動医薬品キオスク市場- 主要動向と促進要因のまとめ

なぜ自動医薬品キオスクはアクセシブルな調剤のためのスケーラブルなソリューションとして台頭しているのか？

自動医薬品キオスクは、従来の薬局カウンターに代わる安全なセルフサービスを提供することで、医薬品へのアクセスを変革しています。これらのキオスクは、病院、診療所、空港、遠隔地などにおいて、処方薬や一般用医薬品を24時間利用できるようにします。これは、薬剤師不足や待ち時間の課題に対処しながら、ラストワンマイルのドラッグデリバリーを合理化するものです。電子的な承認と本人確認によって包装済み医薬品を調剤するように設計されたこれらのシステムは、規制遵守とアクセス管理を保証しながら、患者の利便性を向上させます。

ヘルスケア・プロバイダーや小売薬局は、実店舗の拡張に伴う運営コストを全額負担することなくサービス範囲を拡大するために、こうしたキオスクを導入するケースが増えています。テレヘルスの導入が加速するにつれ、自動キオスクは、バーチャルな診察と物理的な投薬管理の橋渡しをする重要なタッチポイントになりつつあります。電子カルテ（EHR）システムへの統合により、シームレスなポイントオブケア調剤が可能になり、服薬アドヒアランスが向上し、治療開始の遅れが減少します。

技術革新は、医薬品キオスク端末の安全性、コンプライアンス、統合能力をどのように高めているのでしょうか？

最新の自動医薬品キオスクは、高度な安全プロトコル、生体認証、リアルタイムモニタリングを備え、安全でコンプライアンスに準拠した調剤を保証します。薬局管理ソフトウェアやクラウドベースのプラットフォームとの統合により、薬剤師は処方箋の承認、在庫の追跡、補充サイクルの管理を遠隔で行うことができます。ビデオ会議モジュールも、キオスクの自律性を維持しながら、患者と薬剤師との対話を維持し、オンデマンド薬剤師相談を容易にするために追加されています。

改ざん検知、温度管理、監査対応追跡などの規制に沿った機能は、キオスクを機密性の高い薬や管理された薬のためのコンプライアンス・ソリューションとして位置づけています。保険データベースや電子処方箋システムとの統合により、キオスクで直接、資格確認や自己負担金処理が可能になります。より広範なデジタルヘルスエコシステムとの相互運用性が強化されるにつれて、これらのキオスクは、外来患者と慢性期医療の両方のワークフローをサポートできるスマートな分散型薬局ノードへと進化しています。

自動医薬品キオスクの導入が加速している場所と成長を牽引している使用事例は？

リソースの制約に直面しているヘルスケアシステム、特に薬局へのアクセスが制限されている地方や十分なサービスを受けていない地域での導入が加速しています。病院や急患センターでは、キオスクを導入して退院後や時間外の投薬アクセスを提供することで、再入院リスクを低減し、ケアの継続性を高めています。小売薬局チェーンは、ショッピングモールや空港、キャンパスなど、人通りの多い公共スペースでキオスクを試験的に導入し、一般的な医薬品やウェルネス製品への即時アクセスを提供しています。

政府のヘルスケア・プログラムや人道支援団体は、遠隔地や低所得地域における公衆衛生支援活動の一環として、キオスク端末の導入を検討しています。さらに、大規模な雇用主や大学では、従業員の健康管理を合理化するために、ウェルネス・センター内にこうしたシステムを導入しています。使用事例は、管理・追跡可能で効率的な調剤が不可欠な矯正施設、高齢者向けコミュニティ、軍事基地などにも広がっています。

自動医薬品キオスク市場の世界的拡大の原動力は？

市場成長の原動力となっているのは、ヘルスケア消費者意識の高まり、コスト抑制の圧力、薬局サービス全体のデジタル変革の義務化です。患者はますます利便性、プライバシー、24時間365日のアクセスを求めるようになっており、キオスクは従来の調剤コストの数分の一でそれを実現できます。パンデミック時代の非接触型サービスモデルへのシフトは、医薬品ケアの回復力とアクセシビリティを強化する自動調剤の役割をさらに検証しました。

薬局チェーン、医療システム、医療技術企業は、導入規模を拡大し、既存の臨床・薬局ワークフローとの統合を標準化するためにパートナーシップを結んでいます。規制機関は、遠隔調剤モデルを受け入れるためのガイドラインを徐々に更新しており、より広範な受け入れを促しています。ヘルスケアがより分散化し、患者中心主義になるにつれ、核となる疑問が緊急性を増しています。自動医薬品キオスクは、公平性、効率性、服薬アドヒアランスの向上を目指すシステムにおいて、ラストワンマイルの医薬品デリバリーの基幹となり得るのでしょうか？

セグメント

製品タイプ（システム、サービス）;医薬品タイプ（処方箋、OTC、その他の医薬品タイプ）;エンドユース（小売薬局、病院・クリニック、その他のエンドユース）

調査対象企業の例（全34社）

  • Asteres Inc.
  • Bell and Howell
  • BestKiosk
  • Capsa Healthcare
  • Diebold Nixdorf
  • Distributed Delivery Networks Corp.
  • Higi
  • Howell LLC
  • ImageHOLDERS
  • Jadak
  • MC HealthGrid Pvt Ltd.
  • MedAvail Technologies Inc.
  • MedfriendRx
  • Omnicell Inc.
  • PharmcoRx
  • PickPoint
  • Rowa Automatisierungssysteme GmbH
  • ScriptPro LLC
  • Smart RX Systems Inc.
  • Stericycle Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33481

Global Automated Drug Kiosks Market to Reach US$27.3 Billion by 2030

The global market for Automated Drug Kiosks estimated at US$11.6 Billion in the year 2024, is expected to reach US$27.3 Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Automated Drug Kiosk Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$19.6 Billion by the end of the analysis period. Growth in the Automated Drug Kiosk Services segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 14.3% CAGR

The Automated Drug Kiosks market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.4% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Automated Drug Kiosks Market - Key Trends & Drivers Summarized

Why Are Automated Drug Kiosks Emerging as Scalable Solutions for Accessible Pharmaceutical Dispensing?

Automated drug kiosks are transforming medication access by offering secure, self-service alternatives to traditional pharmacy counters. These kiosks provide round-the-clock availability of prescription and over-the-counter drugs in hospitals, clinics, airports, and remote locations-streamlining last-mile pharmaceutical delivery while addressing pharmacist shortages and wait-time challenges. Designed to dispense pre-packaged medications via electronic authorization and identity verification, these systems enhance convenience for patients while ensuring regulatory compliance and controlled access.

Healthcare providers and retail pharmacies are increasingly deploying these kiosks to expand service reach without incurring full operational costs associated with brick-and-mortar expansions. As telehealth adoption accelerates, automated kiosks are becoming critical touchpoints that bridge virtual consultations with physical medication fulfillment. Their integration into electronic health record (EHR) systems enables seamless, point-of-care dispensing, improving medication adherence and reducing delays in treatment initiation.

How Are Technological Innovations Enhancing the Safety, Compliance, and Integration Capabilities of Drug Kiosks?

Modern automated drug kiosks are equipped with advanced safety protocols, biometric authentication, and real-time monitoring to ensure secure and compliant dispensing. Integration with pharmacy management software and cloud-based platforms allows pharmacists to remotely approve prescriptions, track inventory, and manage refill cycles. Video conferencing modules are also being added to facilitate on-demand pharmacist consultations, preserving patient-pharmacist interaction while maintaining kiosk autonomy.

Regulatory-aligned features such as tamper detection, temperature control, and audit-ready tracking are positioning kiosks as compliant solutions even for sensitive or controlled medications. Integration with insurance databases and e-prescription systems enables eligibility verification and copay processing directly at the kiosk. As interoperability with broader digital health ecosystems strengthens, these kiosks are evolving into smart, decentralized pharmacy nodes capable of supporting both outpatient and chronic care workflows.

Where Is Adoption of Automated Drug Kiosks Accelerating and What Use Cases Are Driving Growth?

Adoption is gaining momentum in healthcare systems facing resource constraints, particularly in rural and underserved areas where pharmacy access is limited. Hospitals and urgent care centers are implementing kiosks to provide post-discharge or after-hours medication access, reducing readmission risks and improving continuity of care. Retail pharmacy chains are piloting kiosks in high-traffic public spaces-such as malls, airports, and campuses-to offer instant access to common medications and wellness products.

Government healthcare programs and humanitarian organizations are exploring kiosk deployments as part of public health outreach in remote and low-income regions. Additionally, large employers and universities are adopting these systems within wellness centers to streamline workforce health management. Use cases are also expanding into correctional facilities, senior living communities, and military bases-where controlled, trackable, and efficient dispensing is essential.

What Is Fueling the Global Expansion of the Automated Drug Kiosks Market?

Market growth is being driven by rising healthcare consumerism, cost-containment pressures, and digital transformation mandates across pharmacy services. Patients increasingly demand convenience, privacy, and 24/7 access, which kiosks can deliver at a fraction of traditional dispensing costs. The pandemic-era shift toward contactless service models further validated the role of automated dispensing in enhancing resilience and accessibility in pharmaceutical care.

Pharmacy chains, health systems, and medtech companies are forming partnerships to scale deployment and standardize integration with existing clinical and pharmacy workflows. Regulatory bodies are gradually updating guidelines to accommodate remote dispensing models, encouraging broader acceptance. As healthcare becomes more decentralized and patient-centric, a core question gains urgency: Can automated drug kiosks become the backbone of last-mile medication delivery in a system striving for greater equity, efficiency, and adherence?

SCOPE OF STUDY:

The report analyzes the Automated Drug Kiosks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Systems, Services); Drug Type (Prescriptions, Over-The-Counters, Other Drug Types); End-Use (Retail Pharmacies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Asteres Inc.
  • Bell and Howell
  • BestKiosk
  • Capsa Healthcare
  • Diebold Nixdorf
  • Distributed Delivery Networks Corp.
  • Higi
  • Howell LLC
  • ImageHOLDERS
  • Jadak
  • MC HealthGrid Pvt Ltd.
  • MedAvail Technologies Inc.
  • MedfriendRx
  • Omnicell Inc.
  • PharmcoRx
  • PickPoint
  • Rowa Automatisierungssysteme GmbH
  • ScriptPro LLC
  • Smart RX Systems Inc.
  • Stericycle Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Automated Drug Kiosks - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • 24/7 Dispensing Capability Positions Automated Drug Kiosks as a Pillar of Healthcare Accessibility
    • Integration With e-Prescriptions and EMRs Streamlines Pharmacy Workflow Through Drug Kiosks
    • Retail and Rural Healthcare Expansion Drives Adoption of Automated Drug Dispensing Kiosks
    • Pandemic-Era Contactless Health Trends Accelerate Public Acceptance of Automated Drug Kiosks
    • Regulatory Support for Remote Pharmaceutical Dispensing Enhances Legitimacy of Drug Kiosks
    • Insurance and Reimbursement Integration Improves Affordability of Medications Via Drug Kiosks
    • Compact Footprint and Low Operational Costs Make Automated Drug Kiosks Attractive to Pharmacies
    • AI-Enabled Inventory Management Increases Efficiency and Reduces Stockouts in Drug Kiosks
    • Deployment in Transit Hubs and Workplaces Expands Reach of Automated Drug Kiosk Services
    • Real-Time Access to High-Demand Medications Improves Chronic Disease Adherence Rates
    • Integration With Telepharmacy Platforms Expands Scope of Services Delivered Via Drug Kiosks
    • Automated Drug Kiosks Play a Strategic Role in Decentralizing Healthcare Distribution Networks
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Drug Kiosks Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Prescriptions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Prescriptions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Over-The-Counters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Over-The-Counters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION